Cassava Sciences (SAVA) Secures $149M to Support Simufilam Trials Into 2026
Cassava Sciences Inc. (SAVA) is a clinical-stage biotechnology company at the forefront of advancing treatments for Alzheimer’s disease,…
Browsing Tag